Prophylactic cranial irradiation in small cell lung cancer

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2013

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.

British journal of cancer·2013

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.

British journal of cancer·2013

A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.

Breast (Edinburgh, Scotland)·2012

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study.

British journal of cancer·2010

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Related Experiment Videos

Prophylactic cranial irradiation in small cell lung cancer

Related Concept Videos

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study.

Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy.

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.

A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Related Experiment Videos

Prophylactic cranial irradiation in small cell lung cancer

Related Concept Videos

Related Articles